Your browser does not support JavaScript or it is disabled. Please enable JavaScript to get the full experience.

News & Resources - United Church Funds

October 2018 Market Review

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem

October 2018 Market Commentary

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since

August 2018 Market Review

Following is a summary of the markets and our funds’ performance for the month of August 2018, provided by our Chief Investment Strategist David A. Klassen.

July 2018 Market Review

Lorem Ipsum is simply dummy textLorem Ipsum is simply dummy textLorem Ipsum is simply dummy textLorem Ipsum is simply dummy textLorem Ipsum is simply

Q2 2018 Market and Performance Update

Following is a summary of the markets and our funds’ performance for the second quarter of 2018, provided by our Chief Investment Strategist David Klassen.

Social Issues Proxy Voting Guidelines

The UCF Social Issues Proxy Voting Guidelines.

Introduction to Charitable Gift Annuities

Milly Hernandez, Client Service Team Leader and Planned Giving Associate and Don Hill, President, Don Hill Consulting, explain the key aspects of Charitable Gift Annuities, one of the most popular ways to make a planned gift.

April 2018 Market Review

Following is a summary of the markets and our funds’ performance for the month of April 2018, provided by our Chief Investment Strategist David A. Klassen.

21% of Abbvie Shareholders Favor Report on How Drug Pricing Risks are Integrated Into Exec Incentive Programs

At today’s annual shareholder meeting for Abbvie a first-time shareholder proposal questioning the links between executive compensation packages and drug price increases received a solid show of support from investors, signaling to the board of directors that this issue is key to investor confidence about the long-term sustainability of the company.